Retinyl Palmitate, derivate of vitamin A, is widely used in dermatology and cosmetics due to its anti-ageing and anti-acne properties. Although recognized to be more stable than Retinol itself, Retinyl Palmitate still remains a very sensitive compound, in its original form.
Tagra Microencapsulation RND™ Technology enables optimal isolation of Retinyl Palmitate, protecting it from degradation which may result in skin irritation. Tagravit™ A2 is ideally suitable for topical application, offering formulators and end consumers significant benefits:
- Tagravit™ A2 provides the skin with stable Retinyl Palmitate, ensuring beneficial effects of the
molecule, preventing irritation that could be induced by the molecule degradation.